Concepedia
Statistics
Publications
53
Citations
2.2K
H-Index
25
Active since
1979
Affiliations
Karolinska Institutet(Current)
Medivir (Sweden)
Karolinska University Hospital
Uppsala University
Oncopeptides (Sweden)
Johan Harmenberg is an author at Karolinska Institutet specializing in virology, molecular virology, and antiviral pharmacology.
Publications per year
1979–2021
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Sten Nilsson, Lars Franzén, Christopher Parker et al. · The Lancet Oncology · 2007 · 493 citations
Medicine, Oncology, Radiation Oncology +15
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Paul G. Richardson, Albert Oriol, Alessandra Larocca et al. · Journal of Clinical Oncology · 2020 · 155 citations · Full text
Medicine, Oncology, Pharmacology +14
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs
Johan Harmenberg, Britta Wahrén, J. BERGMAN et al. · Antimicrobial Agents and Chemotherapy · 1988 · 95 citations
Life Sciences, Infectious Diseases, Medicinal Chemistry +14
The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline
Johan Harmenberg, Annelie Åkesson-Johansson, Astrid Gräslund et al. · Antiviral Research · 1991 · 95 citations
Medicine, Medicinal Chemistry, Pharmacology +12
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study
Paul G. Richardson, Sara Bringhen, Peter M. Voorhees et al. · The Lancet Haematology · 2020 · 88 citations
Pharmacy, Oncology, Pharmacotherapy +11
1–5 of 53